SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-12-021373
Filing Date
2012-03-27
Accepted
2012-03-27 15:55:04
Documents
14
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a12-2150_110k.htm 10-K 2367390
2 EX-21.1 a12-2150_1ex21d1.htm EX-21.1 1616
3 EX-23.1 a12-2150_1ex23d1.htm EX-23.1 3751
4 EX-31.1 a12-2150_1ex31d1.htm EX-31.1 9877
5 EX-31.2 a12-2150_1ex31d2.htm EX-31.2 9870
6 EX-32.1 a12-2150_1ex32d1.htm EX-32.1 4073
7 EX-32.2 a12-2150_1ex32d2.htm EX-32.2 4115
14 GRAPHIC g21501bci001.gif GRAPHIC 15147
  Complete submission text file 0001104659-12-021373.txt   6472968

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT pcrx-20111231.xml EX-101.INS 812260
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20111231.xsd EX-101.SCH 18876
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcrx-20111231_cal.xml EX-101.CAL 56622
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT pcrx-20111231_lab.xml EX-101.LAB 325900
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20111231_pre.xml EX-101.PRE 149360
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcrx-20111231_def.xml EX-101.DEF 98574
Mailing Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35060 | Film No.: 12717199
SIC: 2834 Pharmaceutical Preparations